Robert A Kirken Selected Research

Robert A Kirken Research Topics

Disease

15	Neoplasms (Cancer) 12/2022 - 10/2006
6	Lymphoma (Lymphomas) 09/2017 - 10/2006
6	Leukemia 09/2017 - 08/2009
3	Breast Neoplasms (Breast Cancer) 12/2022 - 09/2007
2	Hematologic Neoplasms (Hematological Malignancy) 09/2017 - 05/2012
2	Carcinogenesis 09/2017 - 01/2015
2	Prostatic Neoplasms (Prostate Cancer) 03/2008 - 01/2008
1	Triple Negative Breast Neoplasms 12/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2021
1	Cytokine Release Syndrome 01/2021
1	COVID-19 01/2021
1	Ischemia 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2016
1	Melanoma (Melanoma, Malignant) 01/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2013
1	B-Cell Leukemia (Leukemia, B Cell) 10/2006
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2006

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2006
4	Biomarkers (Surrogate Marker)IBA 02/2021 - 01/2015
3	CytokinesIBA 02/2021 - 05/2012
3	STAT5 Transcription FactorIBA 05/2012 - 01/2008
2	pyrazoleIBA 12/2022 - 06/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2021 - 01/2017
2	NC 1153IBA 01/2016 - 04/2010
2	Interleukin-2 (IL2)IBA 01/2013 - 04/2010
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2010 - 09/2007
2	Tyrosine (L-Tyrosine)FDA Link 08/2009 - 09/2007
2	ProlactinIBA 03/2008 - 01/2008
1	Mitogen-Activated Protein Kinase 3IBA 11/2021
1	Interferon-gamma (Interferon, gamma)IBA 02/2021
1	Fluorouracil (Carac)FDA LinkGeneric 02/2021
1	Celecoxib (Celebrex)FDA Link 02/2021
1	ProdrugsIBA 02/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2021
1	Janus KinasesIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	AzidesIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 09/2017
1	ProhibitinsIBA 09/2017
1	Gemcitabine FDA Link 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Tyrosine Kinase InhibitorsIBA 09/2016
1	tofacitinibIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2015
1	ArsenicIBA 01/2015
1	PhosphatidylserinesIBA 01/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Caspase 3 (Caspase-3)IBA 01/2013
1	Caspase 8 (Caspase-8)IBA 01/2013
1	Serine (L-Serine)FDA Link 05/2012
1	Cyclin D1IBA 03/2008
1	DNA (Deoxyribonucleic Acid)IBA 03/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2008
1	Antisense OligonucleotidesIBA 03/2008
1	Transcription Factors (Transcription Factor)IBA 03/2008
1	Phosphotransferases (Kinase)IBA 03/2008
1	Androgen Receptors (Androgen Receptor)IBA 01/2008
1	Hormones (Hormone)IBA 01/2008
1	NF-kappa B (NF-kB)IBA 10/2006
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2006
1	Interleukin-9 (Interleukin 9)IBA 10/2006
1	Anaplastic Lymphoma KinaseIBA 10/2006

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 02/2021 - 01/2016
3	Therapeutics 01/2017 - 01/2013
1	Combined Modality Therapy 01/2019
1	Molecular Targeted Therapy 01/2019
1	Immunotherapy 01/2017